Clinical trial
Effects of Azithromycin Treatment on Anti-viral Immunity in Patients With Asthma and COPD - A Randomized Double-blind, Placebo-controlled Trial
NCT04319705 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Azithromycin Treatment on Anti-viral Immunity in Patients With Asthma and COPD - A Randomized Double-blind, Placebo-controlled Trial
- Lead sponsor
- Bispebjerg Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 2, 2020
- Completion date
- December 31, 2022
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, asthma; eosinophilic, bronchial diseases, copd, exacerbation copd, immune system diseases, lung diseases, lung diseases, obstructive